Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer

Elizabeth Ward(American Cancer Society), Mary Bohne Havens, Pam Sartori(Roswell Park Comprehensive Cancer Center), Ronald G. Vincent(Roswell Park Comprehensive Cancer Center), Beverly Paigen(Jackson Laboratory), Kyle Steenland(Emory University), Hira L. Gurtoo(Roswell Park Comprehensive Cancer Center), Jun Minowada(Roswell Park Comprehensive Cancer Center)
International Journal of Cancer
October 15, 1978
10.1002/ijc.2910220404
Cited by 48

Related Papers

Cancer treatment and survivorship statistics, 2012
|CA A Cancer Journal for Clinicians|2012|2.9k
Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
|Cancer|2013|1.3k
The Collaborative Cross, a community resource for the genetic analysis of complex traits
|Nature Genetics|2004|1.2k
Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|954
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.
|PubMed|1972|650